کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2196199 | 1550908 | 2013 | 7 صفحه PDF | دانلود رایگان |

NADPH oxidase-1 (NOX-1) is upregulated in beta cells in response to pro-inflammatory cytokines. Inhibition of NADPH oxidase activity blocked stimulated NOX-1 expression (p < 0.05). Regulation of NOX-1 expression in beta cells followed modulation of cellular reactive oxygen species (ROS); pro-oxidants increased NOX-1 (p < 0.001) and anti-oxidants decreased NOX-1 (p < 0.05). Activation of Src-kinase followed ROS elevation. Inhibition of Src-kinase decreased NOX-1 expression (p < 0.01). Beta cell dysfunction, measured by elevated MCP-1 expression, loss of glucose-sensitive insulin secretion or cell death, was induced by pro-inflammatory cytokine stimulation. Importantly, inhibition of Src-kinase or NOX-1 preserved beta cell function and survival. Collectively, these data indicate that expression of NOX-1 in beta cells is regulated in a feed-forward loop mediated by ROS and Src-kinase. Uncoupling of this feed-forward activation could provide new approaches to preserve and protect beta cells in diabetes.
► Pro-inflammatory cytokines induce NADPH oxidase-1 expression in beta cells.
► Inhibitors of NADPH oxidase block NOX-1 expression in beta cells.
► Cellular reactive oxygen species levels modulate NOX-1 expression in beta cells.
► Src-kinase activation by cellular reactive oxygen species activates NOX-1 expression.
► Feedback regulation of NOX-1 in β-cells, an enticing therapeutic target in diabetes.
Journal: Molecular and Cellular Endocrinology - Volume 369, Issues 1–2, 30 April 2013, Pages 35–41